Xploro, the award-winning healthcare platform for children, has closed its first major US funding round.
The mobile application company uses 3D augmented reality interactive models, an artificially intelligent avatar guide and games to introduce young patients to hospital environments, staff and clinical diagnosis and treatment processes.
Xploro, which has recently established new headquarters in Cleveland, Ohio, has also made its first US hire with the recruitment of Stefan Agamanolis as chief strategy officer to head up North American operations.
Dom Raban, Xploro’s founder and CEO, said: “These are exciting times for Xploro. This funding is crucial for the company’s growth and means we can offer an improved product to healthcare providers and users.
“Clinicians will find more value in the back end and the kids that use it will benefit from better and more engaging content which will support their healthcare journey.”
The size of the fundraise has not been revealed but it was led by Comeback Capital, with University Hospitals Ventures and JumpStart Ventures (both through their joint Healthcare Collaboration Fund), and Rightside Capital Management.
Also joining the cap table are CareFirst BlueCross BlueShield and LifeBridge Health whose SAFEs converted with this round.
New chief strategy officer Stefan Agamanolis said: “Xploro is a unique platform that is proving it can meaningfully empower children and teens in their healthcare journey.
“It is a tremendous example of what is possible when combining the latest technologies with inspired design, in this case for the benefit of young patients, and their families and healthcare providers. I am excited to join the team and help take Xploro to the next level!”
Funding sought for Xploro app to support siblings of seriously ill children
A software engineer and interaction designer by background, he spent the last 12 years at Akron Children’s Hospital in Ohio, initially as associate director of research, then senior director of patient experience, and then for the last four years as chief innovation officer.
Xploro’s technology will target children initially but the aim is to expand it to any patient, of any age, with any condition, anywhere in the world.